Literature DB >> 19944185

TP53 mutation profile of esophageal squamous cell carcinomas of patients from Southeastern Brazil.

Ana Rossini1, Tatiana de Almeida Simão, Cynthia B Marques, Sheila C Soares-Lima, Suellen Herbster, Davy Carlos M Rapozo, Nelson A Andreollo, Maria A Ferreira, Kenya Balbi El-Jaick, Roberto Teixeira, Denise P Guimarães, Rodolpho Mattos Albano, Luis Felipe Ribeiro Pinto.   

Abstract

Esophageal cancer (EC) is among the 10 most common and fatal malignacies in the world, presenting a marked geographic variation in incidence rates between and within different countries. The TP53 tumor suppressor gene is highly mutated in esophageal tumors and its mutation pattern can offer clues to the etiopathology of the tumor. As Brazil presents one of the highest incidence areas in the West, a deeper knowledge of the molecular mechanisms related to EC development in the Brazilian population is needed. We analyzed the mutation profile of 110 esophageal squamous cell carcinomas (ESCC) of patients from Southeastern Brazil (Rio de Janeiro and São Paulo) and collected data regarding alcohol intake and tobacco smoking. We detected 41 mutations in tumor samples from 38 patients. There was no association between mutation frequency and tobacco smoking or alcohol drinking. The most frequently mutated codons were 179, 214, 220 and 248. Codons 179, 220 and 248 are hot-spots for ESCC, but codon 214 presents only 0.7% of the mutations registered in the IARC database. The mutation profile revealed a high percentage of mutations at A:T base pairs (34.1%) followed by deletions (17.1%). We concluded that the mutation profile detected in this study is different from that of patients from Southern Brazil but very similar to that previously seen in French patients, being characterized by a high frequency of mutations at A:T base pairs, which may be associated with acetaldehyde, the metabolic product of ethanol.
Copyright © 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19944185     DOI: 10.1016/j.mrgentox.2009.11.005

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

Review 1.  International cancer seminars: a focus on esophageal squamous cell carcinoma.

Authors:  G Murphy; V McCormack; B Abedi-Ardekani; M Arnold; M C Camargo; N A Dar; S M Dawsey; A Etemadi; R C Fitzgerald; D E Fleischer; N D Freedman; A M Goldstein; S Gopal; M Hashemian; N Hu; P L Hyland; B Kaimila; F Kamangar; R Malekzadeh; C G Mathew; D Menya; G Mulima; M M Mwachiro; A Mwasamwaja; N Pritchett; Y-L Qiao; L F Ribeiro-Pinto; M Ricciardone; J Schüz; F Sitas; P R Taylor; K Van Loon; S-M Wang; W-Q Wei; C P Wild; C Wu; C C Abnet; S J Chanock; P Brennan
Journal:  Ann Oncol       Date:  2017-09-01       Impact factor: 32.976

2.  High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations.

Authors:  Chi Hoon Maeng; Jeeyun Lee; Paul van Hummelen; Se Hoon Park; Emanuele Palescandolo; Jiryeon Jang; Ha Young Park; So Young Kang; Laura MacConaill; Kyoung-Mee Kim; Young-Mog Shim
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

3.  Extremely high Tp53 mutation load in esophageal squamous cell carcinoma in Golestan Province, Iran.

Authors:  Behnoush Abedi-Ardekani; Farin Kamangar; Masoud Sotoudeh; Stephanie Villar; Farhad Islami; Karim Aghcheli; Dariush Nasrollahzadeh; Noushin Taghavi; Sanford M Dawsey; Christian C Abnet; Stephen M Hewitt; Saman Fahimi; Farrokh Saidi; Paul Brennan; Paolo Boffetta; Reza Malekzadeh; Pierre Hainaut
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

Review 4.  The potential of molecular markers to improve interventions through the natural history of oesophageal squamous cell carcinoma.

Authors:  Nathalia Meireles da Costa; Sheila Coelho Soares Lima; Tatiana de Almeida Simão; Luis Felipe Ribeiro Pinto
Journal:  Biosci Rep       Date:  2013-08-14       Impact factor: 3.840

5.  Atorvastatin Downregulates In Vitro Methyl Methanesulfonate and Cyclophosphamide Alkylation-Mediated Cellular and DNA Injuries.

Authors:  Carlos F Araujo-Lima; Larissa S A Christoni; Graça Justo; Maria N C Soeiro; Claudia A F Aiub; Israel Felzenszwalb
Journal:  Oxid Med Cell Longev       Date:  2018-04-03       Impact factor: 6.543

6.  Mutations, Differential Gene Expression, and Chimeric Transcripts in Esophageal Squamous Cell Carcinoma Show High Heterogeneity.

Authors:  Paulo Thiago de Souza-Santos; Sheila Coelho Soares Lima; Pedro Nicolau-Neto; Mariana Boroni; Nathalia Meireles Da Costa; Lilian Brewer; Albert Nobre Menezes; Carolina Furtado; Miguel Angelo Martins Moreira; Hector N Seuanez; Tatiana de Almeida Simão; Luis Felipe Ribeiro Pinto
Journal:  Transl Oncol       Date:  2018-08-29       Impact factor: 4.243

7.  Profile of esophageal squamous cell carcinoma mutations in Brazilian patients.

Authors:  Fernanda Franco Munari; Wellington Dos Santos; Adriane Feijó Evangelista; Ana Carolina Carvalho; Paula Aguiar Pastrez; Diego Bugatti; Durval R Wohnrath; Cristovam Scapulatempo-Neto; Denise Peixoto Guimarães; Adhemar Longatto-Filho; Rui Manuel Reis
Journal:  Sci Rep       Date:  2021-10-18       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.